XETRA · FRE.DE
Fresenius SE & Co. KGaA
€47.00+€0.67 (+1.44%)
Fresenius SE & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
Loading market information…
OTC · JNHMF · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Jack Nathan Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Jack Nathan Medical Corp., together with its associated entities, focuses on operating primary care medical clinics. These facilities, known as Jack Nathan Health, are primarily situated within Walmart Supercentres. The company was founded in 2006 and its corporate headquarters are located in Woodbridge, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€47.00+€0.67 (+1.44%)
Fresenius SE & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
A$55.66+A$0.74 (+1.35%)
Ramsay Health Care Limited’s quoted price sits in the upper half of its reported 52-week range, 0.78% below the high.
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
CA$14.70+CA$0.03 (+0.2%)
Medical Facilities Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.77% below the high.
CA$0.50+CA$0.07 (+16.28%)
Nova Leap Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
$0.01$0.00 (0.0%)
JRSIS Health Care Corporation’s quoted price sits in the lower half of its reported 52-week range, 93.5% below the high.
$0.01$0.00 (0.0%)
Aesthetic Medical International Holdings Group Limited’s quoted price sits in the lower half of its reported 52-week range, 96.25% below the high.
